Antipsychotic dosing: found in translation.

Area of Science:

• Psychiatry
• Schizophrenia Research
• Neuroscience

Background:

• Schizophrenia research has seen limited clinical translation, causing frustration with existing strategies.
• Many research findings fail to impact diagnosis and treatment effectively.
• However, progress in understanding antipsychotic dosing offers a counterexample.

Purpose of the Study:

• To highlight research advances that have successfully translated to clinical practice in schizophrenia.
• To examine the impact of preclinical and clinical research on antipsychotic dosing strategies.
• To discuss future implications for antipsychotic administration in schizophrenia treatment.

Main Methods:

• Review of preclinical and clinical research findings.
• Analysis of evidence demonstrating shifts in clinical practice regarding antipsychotic dosing.
• Examination of historical trends in antipsychotic administration over six decades.

Main Results:

• Specific research lines have substantially altered the approach to antipsychotic dosing.
• Evidence exists that has already shifted clinical practice in schizophrenia treatment.
• The translation of research findings into clinical practice is variable but impactful in certain areas.

Conclusions:

• Advances 'found in translation' are crucial for improving schizophrenia care.
• The evolution of antipsychotic dosing strategies demonstrates successful research translation.
• Further research is needed to refine and optimize antipsychotic administration for better patient outcomes.